FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164174927> ?p ?o ?g. }

• W2164174927 endingPage "461" @default.
• W2164174927 startingPage "459" @default.
• W2164174927 abstract "HomeCirculation ResearchVol. 99, No. 5Estrogen and Different Aspects of Vascular Disease in Women and Men Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBEstrogen and Different Aspects of Vascular Disease in Women and Men Carl J. Pepine, Wilmer W. Nichols and Daniel F. Pauly Carl J. PepineCarl J. Pepine From the Division of Cardiovascular Medicine, University of Florida College of Medicine Search for more papers by this author , Wilmer W. NicholsWilmer W. Nichols From the Division of Cardiovascular Medicine, University of Florida College of Medicine Search for more papers by this author and Daniel F. PaulyDaniel F. Pauly From the Division of Cardiovascular Medicine, University of Florida College of Medicine Search for more papers by this author Originally published1 Sep 2006https://doi.org/10.1161/01.RES.0000241056.84659.59Circulation Research. 2006;99:459–461is corrected byCorrectionConsiderable evidence indicates that sex hormones have an important influence on cardiovascular physiology and pathology.1,2 Recent work suggests that a mechanism based on estrogen receptor-alpha (ESR1) contributes to a range of structural and functional responses that relate to vascular disease. Most of this work focuses on ESR1 activity within the endothelium and yields variable findings due, at least in part, to differences in the vascular bed or species studied, as well as other experimental conditions such as age, estrogen status, degree of preconstriction, etc. But many findings in conduit arteries (eg, more frequent plaque erosion, increased wall stiffness, spasm, etc) and microvessels (eg, reduced coronary flow reserve, hot flashes, etc) implicate smooth muscle cells (SMCs) in gender differences in vascular disease. These cells are directly responsible for extracellular matrix production and assure the integrity of the artery wall. They may be decreased, apoptotic, or dysfunctional in terms of synthesis and repair of extracellular matrix, which is destroyed in vulnerable plaque by macrophages.In this issue of Circulation Research Montague and colleagues3 report that activation of ESR1 decreases human aorta SMC differentiation (Figure). Importantly, they found that SMCs of men, compared with women, had reduced ESR1 expression associated with increased differentiation markers. Their work suggests that ESR1 activation switches SMC to a form that may promote plaque vulnerability. Could different activational states of ESR1 be responsible for shifting the functional characteristics of SMCs toward a phenotype that explains some complexities of gender-related differences in vascular disease? Download figureDownload PowerPointHypothetical construct based on Montague et al suggests that the activational state of estrogen receptor-alpha (ESR1) governs the vascular smooth muscle (SMC) phenotype. Among men with lower ESR1 expression they identified higher levels of differentiation markers compared with women. However activation of ESR1 in SMCs containing low ESR1 expression reduced differentiation markers and promoted apoptosis. This was accomplished by the authors using lentivirus transduction. Conversely, inhibiting ESR1 in SMCs expressing high levels of interfering RNA (SiRNA). The balance between these mechanisms could contribute to vascular remodeling and plaque instability.Differences in Vascular Disease Between Women and MenRisk conditions and clinical findings indicate that the pathophysiology underlying ischemic vascular disease differs between women and men.4 A number of conditions are unique to women (eg, early age at menopause, hypertensive disorders of pregnancy, gestational diabetes, peripartum aortic or coronary dissection, polycystic ovarian syndrome, hypothalamic hypoestrogenemia, etc). Other factors linked with vascular disease or dysfunction are much more frequent in women than men (eg, migraine, coronary spasm, vasculitis, Raynaud phenomenon, etc). On this background, postmenopausal women more frequently have many traditional vascular disease risk conditions (eg, diabetes, obesity, hypertension, inactivity, etc) which occur and cluster more frequently in women than men. In addition to this greater burden of risk factors, the woman with vascular disease often is older and has more functional disability than her male counterpart.5,6 Women have poor clinical outcomes compared with men with acute coronary syndromes,7 chronic coronary syndromes,8 coronary revascularization,9 and heart failure10 that cannot be explained by simply adjusting for age. So other factors must contribute to the increased severity of vascular disease in women compared with men.Clinical Characteristics and Links With Sex HormonesAlthough, ischemic vascular disease is the most frequent cause of death for women, its prevalence in women compared with men does not increase markedly until after menopause when major changes in sex hormones occur. During menopause estrogen levels are about one-tenth premenopausal levels and the predominant source, estradiol, changes to estrone produced by conversion of androgens in adipose tissue.1,6 Age-dependent aromatase expression in SMCs provides a mechanism for local production of estrogens from androgens.11 Aging attenuates many estrogen-related potentially beneficial responses.12 Yet, we have observed that central-induced endogenous estrogen deficiency in younger women is associated with a >7-fold increase in risk of coronary obstruction.13 One interpretation is the widely varying estrogen/androgen balance occurring throughout a woman’s life contributes to differences in vascular disease compared with men. This includes high levels of estrogen premenopause and decreasing estrogen and progesterone levels postmenopause, along with changing hormone balance during pregnancy, peripartum, and oral contraceptive or replacement therapy. Such varying estrogen/androgen balance interacts with the female unique and traditional risk conditions, as well as diet (eg, phytoestrogens, etc), physical activity, psychosocial characteristics, etc, to modulate differences in vascular disease.Estrogen exerts effects via 2 receptors abundant in vascular tissue to transduce signals regulating expression of many genes, and it also has nongenomic effects.1 Considerable evidence implicates the ESR1 in vascular structure and function. Attempts to link estrogen receptor-alpha gene (ESR1) variation with adverse outcomes yield mixed results.14–19 Recently an overview of 5 studies including >7000 men suggested a 44% excess risk of myocardial infarction associated with the CC genotype at ESR1 c454–397T>C,20 strengthening the finding of an almost 2-fold increased risk of stroke associated with this CC genotype among 2709 of these men.21 Yet a study in 3404 postmenopausal women provided no evidence for an association of ESR1 genotypes or haplotypes with vascular outcomes.22 In light of Montague and colleagues’3 work, could variation in activation of ESR1 and changes in SMCs explain this link with vascular outcomes among men but not women? Clearly a better understanding is needed of the characteristics of SMCs of women and men among various phenotypes of ischemic vascular disease or ideally even before vascular disease becomes clinically apparent.Estrogen and Sex/Gender-Related Differences in Blood VesselsWomen have smaller and stiffer conduit arteries than men even when adjusted for height, weight, and arterial pressure,23,24 contributing to earlier return of reflected arterial pulse waves, widened pulse pressure, and adverse effects on myocardial oxygen supply and demand. We found brachial pulse pressure to be the best independent predictor of cardiovascular adverse outcomes among blood pressure measures,25 suggesting that elastic properties of conduit arteries are important in the vasculopathy of women.Changes in artery size (eg, remodeling) may occur in response to physiologic (eg, pregnancy, exercise, etc) or pathologic (eg, atherosclerosis, hypertension, etc) stimuli. Insight into potentially pathologic gender-related differences in remodeling comes from cardiac transplant recipients and transgender patients. Female hearts transplanted to females show little change in coronary size over time.26 But female hearts transplanted to males show progressive coronary enlargement, independent of body size and left ventricular hypertrophy, that persist over time. Links between sex hormones and differences in arterial size are strengthened by studies of transsexuals where brachial artery size in genetic males taking estrogens is smaller compared with control males.27,28 Genetic females taking androgens have larger arteries than control females.29 Androgen-deprivation therapy in genetic males is associated with smaller brachial artery size compared with control males.30 These findings support the notion that sex hormone balance has different, and under certain circumstances opposite, effects on conduit artery remodeling with an androgen state causing positive remodeling compared with an estrogen state. Positive remodeling is not invariably a compensating response and is also a marker of vascular disease.31 Positive remodeling as a marker for plaque vulnerable to rupture or erosion could be linked with the high event rate observed among women with normal or non-obstructive coronary angiographic findings.32–34The findings of Montague et al3 of differential effects of ESR1 activation on SMC function advance our understanding the role of estrogen in regulation of vascular physiology and pathology. These findings should shed light on the complexities of gender-related vascular disease.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.Sources of FundingThis work was supported by contracts from the National Heart, Lung, and Blood Institutes, nos. N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164, grants U0164829, U01 HL649141, U01 HL649241, a GCRC grant MO1-RR00425 from the National Center for Research Resources, and grants from the Gustavus and Louis Pfeiffer Research Foundation, Denville, New Jersey, The Women’s Guild of Cedars-Sinai Medical Center, Los Angeles, California, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, Pennsylvania, and QMED, Inc, Laurence Harbor, New Jersey.DisclosuresNone.FootnotesCorrespondence to Carl J. Pepine, MD, Division of Cardiovascular Medicine, University of Florida College of Medicine, 1600 SW Archer Road/Box 100277, Gainesville, FL 32610-0277. E-mail [email protected] References 1 Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004; 286: R233–R249.CrossrefMedlineGoogle Scholar2 Pepine CJ. Ischemic heart disease in women: facts and wishful thinking. J Am Coll Cardiol. 2004; 43: 1727–1730.CrossrefMedlineGoogle Scholar3 Montague CR, Hunter MG, Gavrilin MA, Phillips GS, Goldschmidt-Clermont PJ, Marsh CB. Activation of estrogen receptor-a reduces aortic smooth muscle differentiation. Circ Res. 2006; 99: 477–484.LinkGoogle Scholar4 Pepine CJ, Kerensky RA, Lambert CR, Smith KM, von Mering GO, Sopko G, Bairey Merz CN. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol. 2006; 47: S30–S35.CrossrefMedlineGoogle Scholar5 Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006; 47: S21–S29.CrossrefMedlineGoogle Scholar6 Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006; 47: S4–S20.CrossrefMedlineGoogle Scholar7 Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999; 341: 217–225.CrossrefMedlineGoogle Scholar8 Daly C, Clemens F, Lopez Sendon JL, Tavazzi L, Boersma E, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F, Fox KM. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006; 113: 490–498.LinkGoogle Scholar9 Humphries KH, Gao M, Lichtenstein SV, Thompson CR. Mortality in women after coronary artery bypass surgery really is higher. Circulation. 2005; 111: E42–E43.Google Scholar10 Philbin EF, DiSalvo TG. Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. Am J Cardiol. 1998; 82: 76–81.CrossrefMedlineGoogle Scholar11 Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H, Takagi Y. Localized expression of aromatase in human vascular tissues. Circ Res. 1999; 84: 1285–1291.CrossrefMedlineGoogle Scholar12 Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348: 593–600.CrossrefMedlineGoogle Scholar13 Bairey Merz CN, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, Hodgson TK, Matthews KA, Pepine CJ, Reis SE, Reichek N, Rogers WJ, Pohost GM, Kelsey SF, Sopko G. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol. 2003; 41: 413–419.CrossrefMedlineGoogle Scholar14 Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Brosnihan KB, Meyers DA, Bleecker ER. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med. 2002; 346: 967–974.CrossrefMedlineGoogle Scholar15 Lehtimaki T, Kunnas TA, Mattila KM, Perola M, Penttila A, Koivula T, Karhunen PJ. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J Mol Med. 2002; 80: 176–180.CrossrefMedlineGoogle Scholar16 Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Meyers DA, Bleecker ER. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation. 2002; 105: 1879–1882.LinkGoogle Scholar17 Koivu TA, Fan YM, Mattila KM, Dastidar P, Jokela H, Nikkari ST, Kunnas T, Punnonen R, Lehtimaki T. The effect of hormone replacement therapy on atherosclerotic severity in relation to ESR1 genotype in postmenopausal women. Maturitas. 2003; 44: 29–38.CrossrefMedlineGoogle Scholar18 Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH, Mendelsohn ME, Housman DE, Levy D. Association between estrogen receptor alpha gene variation and cardiovascular disease. J Am Med Assoc. 2003; 290: 2263–2270.CrossrefMedlineGoogle Scholar19 Schuit SC, Oei HH, Witteman JC, Geurts van Kessel CH, van Meurs JB, Nijhuis RL, van Leeuwen JP, de Jong FH, Zillikens MC, Hofman A, Pols HA, Uitterlinden AG. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. J Am Med Assoc. 2004; 291: 2969–2977.CrossrefMedlineGoogle Scholar20 Shearman AM, Cooper JA, Kotwinski PJ, Miller GJ, Humphries SE, Ardlie KG, Jordan B, Irenze K, Lunetta KL, Schuit SC, Uitterlinden AG, Pols HA, Demissie S, Cupples LA, Mendelsohn ME, Levy D, Housman DE. Estrogen receptor alpha gene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circ Res. 2006; 98: 590–592.LinkGoogle Scholar21 Shearman AM, Cooper JA, Kotwinski PJ, Humphries SE, Mendelsohn ME, Housman DE, Miller GJ. Estrogen receptor alpha gene variation and the risk of stroke. Stroke. 2005; 36: 2281–2282.LinkGoogle Scholar22 Lawlor DA, Timpson N, Ebrahim S, Day IN, Smith GD. The association of oestrogen receptor {alpha}-haplotypes with cardiovascular risk factors in the British Women’s Heart and Health Study. Eur Heart J. 2006; 27: 1597–1604.CrossrefMedlineGoogle Scholar23 Gatzka CD, Kingwell BA, Cameron JD, Berry KL, Liang YL, Dewar EM, Reid CM, Jennings GL, Dart AM. Gender differences in the timing of arterial wave reflection beyond differences in body height. J Hypertens. 2001; 19: 2197–2203.CrossrefMedlineGoogle Scholar24 Sheifer SE, Canos MR, Weinfurt KP, Arora UK, Mendelsohn FO, Gersh BJ, Weissman NJ. Sex differences in coronary artery size assessed by intravascular ultrasound. Am Heart J. 2000; 139: 649–653.CrossrefMedlineGoogle Scholar25 Sizemore BC, Barrow G, Johnson BD, Kip K, von Mering GO, Kerensky RA, Handberg E, Pepine CJ Pulse pressure is a stronger predictor of mortality and cardiovascular events than systolic blood pressure in women: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study. Circulation. 2005; 112: II-678. Abstract.Google Scholar26 Herity NA, Lo S, Lee DP, Ward MR, Filardo SD, Yock PG, Fitzgerald PJ, Hunt SA, Yeung AC. Effect of a change in gender on coronary arterial size: a longitudinal intravascular ultrasound study in transplanted hearts. J Am Coll Cardiol. 2003; 41: 1539–1546.CrossrefMedlineGoogle Scholar27 New G, Timmins KL, Duffy SJ, Tran BT, O’Brien RC, Harper RW, Meredith IT. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol. 1997; 29: 1437–1444.CrossrefMedlineGoogle Scholar28 McCrohon JA, Walters WA, Robinson JT, McCredie RJ, Turner L, Adams MR, Handelsman DJ, Celermajer DS. Arterial reactivity is enhanced in genetic males taking high dose estrogens. J Am Coll Cardiol. 1997; 29: 1432–1436.CrossrefMedlineGoogle Scholar29 McCredie RJ, McCrohon JA, Turner L, Griffiths KA, Handelsman DJ, Celermajer DS. Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol. 1998; 32: 1331–1335.CrossrefMedlineGoogle Scholar30 Herman SM, Robinson JT, McCredie RJ, Adams MR, Boyer MJ, Celermajer DS. Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler Thromb Vasc Biol. 1997; 17: 2004–2009.CrossrefMedlineGoogle Scholar31 Lerman A, Cannan CR, Higano SH, Nishimura RA, Holmes DR Jr. Coronary vascular remodeling in association with endothelial dysfunction. Am J Cardiol. 1998; 81: 1105–1109.CrossrefMedlineGoogle Scholar32 Hoffmann U, Moselewski F, Nieman K, Jang IK, Ferencik M, Rahman AM, Cury RC, Abbara S, Joneidi-Jafari H, Achenbach S, Brady TJ. Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol. 2006; 47: 1655–1662.CrossrefMedlineGoogle Scholar33 Holubkov R, Karas RH, Pepine CJ, Rickens CR, Reichek N, Rogers WJ, Sharaf BL, Sopko G, Merz CN, Kelsey SF, McGorray SP, Reis SE. Large brachial artery diameter is associated with angiographic coronary artery disease in women. Am Heart J. 2002; 143: 802–807.CrossrefMedlineGoogle Scholar34 Khuddus MA, Sizemore BC, Bairey Merz CN, Pepine CJ, McGorray SP, Handberg EM, Smith KM, Sopko G, Sharaf B, Nissen SE, von Mering GO. Coronary atherosclerosis by intravascular ultrasound in women with suspected myocardial ischemia, but no or minimal angiographic disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol. 2006; 47: 329A. Abstract.Google Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Salwierz P, Davenport C, Sumra V, Iulita M, Ferretti M and Tartaglia M (2022) Sex and gender differences in dementia Sex and Gender Differences in Neurological Disease, 10.1016/bs.irn.2022.07.002, (179-233), . Sabra D, Intzandt B, Desjardins-Crepeau L, Langeard A, Steele C, Frouin F, Hoge R, Bherer L, Gauthier C and Rypma B (2021) Sex moderations in the relationship between aortic stiffness, cognition, and cerebrovascular reactivity in healthy older adults, PLOS ONE, 10.1371/journal.pone.0257815, 16:9, (e0257815) Yang H, Kim H and Lee H (2021) The Effectiveness of Ecklonia Cava Kjellman Extract in Improving Menopausal Syndrome in Osteoporosis and Depression, Applied Sciences, 10.3390/app11125315, 11:12, (5315) Wu H, Nie P, Zhou Z, Hu J, Li G, Zhang M, Tian Z, Yang X, Ni B and Chen K S-(–)-equol alleviates stenosis of the injured carotid artery in Sprague Dawley rats by preventing the vascular smooth muscle cell phenotypic switch via inhibition of the MAPK p38 -NFκB p65 signaling , Materials Express, 10.1166/mex.2020.1731, 10:8, (1237-1248) Eikendal A, den Ruijter H, Haaring C, Saam T, van der Geest R, Westenberg J, Bots M, Hoefer I and Leiner T (2017) Sex, body mass index, and blood pressure are related to aortic characteristics in healthy, young adults using magnetic resonance vessel wall imaging: the AMBITYON study, Magnetic Resonance Materials in Physics, Biology and Medicine, 10.1007/s10334-017-0626-z, 31:1, (173-182), Online publication date: 1-Feb-2018. Al-Gburi S, Deussen A, Zatschler B, Weber S, Künzel S, El-Armouche A, Lorenz K, Cybularz M, Morawietz H and Kopaliani I (2017) Sex-difference in expression and function of beta-adrenoceptors in macrovessels: role of the endothelium, Basic Research in Cardiology, 10.1007/s00395-017-0617-2, 112:3, Online publication date: 1-May-2017. Eikendal A, Bots M, Haaring C, Saam T, van der Geest R, Westenberg J, den Ruijter H, Hoefer I, Leiner T and Jefferies J (2016) Reference Values for Cardiac and Aortic Magnetic Resonance Imaging in Healthy, Young Caucasian Adults, PLOS ONE, 10.1371/journal.pone.0164480, 11:10, (e0164480) Perdomo S, Moody A, McCoy S, Barinas-Mitchell E, Jakicic J and Gibbs B (2016) Effects on carotid–femoral pulse wave velocity 24 h post exercise in young healthy adults, Hypertension Research, 10.1038/hr.2015.161, 39:6, (435-439), Online publication date: 1-Jun-2016. Soffler M, McGregor A and Safdar B (2016) It’s not all Chest Pain: Sex and Gender in Acute Care Cardiology Sex and Gender in Acute Care Medicine, 10.1017/CBO9781107705944.004, (6-23) Langenkamp E, Zhang L, Lugano R, Huang H, Elhassan T, Georganaki M, Bazzar W, Lööf J, Trendelenburg G, Essand M, Pontén F, Smits A and Dimberg A (2015) Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival, Cancer Research, 10.1158/0008-5472.CAN-14-3636, 75:21, (4504-4516), Online publication date: 1-Nov-2015. Safari T, Nematbakhsh M, Evans R and Denton K (2015) High-Dose Estradiol-Replacement Therapy Enhances the Renal Vascular Response to Angiotensin II via an AT 2 -Receptor Dependent Mechanism , Advances in Pharmacological Sciences, 10.1155/2015/682745, 2015, (1-7), . Touyz R and Montezano A (2015) Hypertensive Vasculopathy PanVascular Medicine, 10.1007/978-3-642-37078-6_51, (1595-1618), . Touyz R and Montezano A (2014) Hypertensive Vasculopathy PanVascular Medicine, 10.1007/978-3-642-37393-0_51-1, (1-28), . Segatto M, Di Giovanni A, Marino M and Pallottini V (2013) Analysis of the protein network of cholesterol homeostasis in different brain regions: An age and sex dependent perspective, Journal of Cellular Physiology, 10.1002/jcp.24315, 228:7, (1561-1567), Online publication date: 1-Jul-2013. Han G, Li F, Yu X and White R (2013) GPER: A novel target for non-genomic estrogen action in the cardiovascular system, Pharmacological Research, 10.1016/j.phrs.2013.02.008, 71, (53-60), Online publication date: 1-May-2013. Kett M and Denton K (2011) Renal programming: cause for concern?, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.00791.2010, 300:4, (R791-R803), Online publication date: 1-Apr-2011. Orekhov A, Andreeva E, Andrianova I and Bobryshev Y (2010) Peculiarities of cell composition and cell proliferation in different type atherosclerotic lesions in carotid and coronary arteries, Atherosclerosis, 10.1016/j.atherosclerosis.2010.07.009, 212:2, (436-443), Online publication date: 1-Oct-2010. Casazza K, Page G and Fernandez J (2010) The Association Between the rs2234693 and rs9340799 Estrogen Receptor α Gene Polymorphisms and Risk Factors for Cardiovascular Disease: A Review, Biological Research For Nursing, 10.1177/1099800410371118, 12:1, (84-97), Online publication date: 1-Jul-2010. Pepine C, Anderson R, Sharaf B, Reis S, Smith K, Handberg E, Johnson B, Sopko G and Bairey Merz C (2010) Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia, Journal of the American College of Cardiology, 10.1016/j.jacc.2010.01.054, 55:25, (2825-2832), Online publication date: 1-Jun-2010. Flinsenberg T, van der Sterren S, van Cleef A, Schuurman M, Ågren P and Villamor E (2010) Effects of sex and estrogen on chicken ductus arteriosus reactivity, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.00839.2009, 298:5, (R1217-R1224), Online publication date: 1-May-2010. Faxon D (2009) Women Are Like Men … Sometimes**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology., Journal of the American College of Cardiology, 10.1016/j.jacc.2009.06.044, 54:21, (1946-1948), Online publication date: 1-Nov-2009. Buja P, Zuin G, Di Pede F, Madalosso M, Grassi G, Celestre M, Millosevich P, Rigo F and Raviele A (2008) Long-term outcome and sex distribution across ages of left ventricular apical ballooning syndrome, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e3282fec072, 9:9, (905-909), Online publication date: 1-Sep-2008. Sampson A, Widdop R and Denton K (2008) SEX-DIFFERENCES IN CIRCADIAN BLOOD PRESSURE VARIATIONS IN RESPONSE TO CHRONIC ANGIOTENSIN II INFUSION IN RATS, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.2008.04884.x, 35:4, (391-395), Online publication date: 1-Apr-2008. Meyer M, Haas E and Barton M (2008) Need for research on estrogen receptor function: Importance for postmenopausal hormone therapy and atherosclerosis, Gender Medicine, 10.1016/j.genm.2008.03.004, 5, (S19-S33), Online publication date: 1-Jan-2008. Nichols W, Pierce G and Braith R (2014) Does hormone treatment alter arterial properties in postmenopausal women?, Expert Review of Endocrinology & Metabolism, 10.1586/17446651.2.5.653, 2:5, (653-665), Online publication date: 1-Sep-2007. Barton M, Meyer M and Haas E (2007) Hormone Replacement Therapy and Atherosclerosis in Postmenopausal Women, Arteriosclerosis, Thrombosis, and Vascular Biology, 27:8, (1669-1672), Online publication date: 1-Aug-2007. Pico-Alfonso M, Mastorci F, Ceresini G, Ceda G, Manghi M, Pino O, Troisi A and Sgoifo A (2007) Acute psychosocial challenge and cardiac autonomic response in women: The role of estrogens, corticosteroids, and behavioral coping styles, Psychoneuroendocrinology, 10.1016/j.psyneuen.2007.02.009, 32:5, (451-463), Online publication date: 1-Jun-2007. Pepine C and Nichols W (2007) The pathophysiology of chronic ischemic heart disease, Clinical Cardiology, 10.1002/clc.20048, 30:S1, (I4-I9), Online publication date: 1-Feb-2007. Related articlesCorrectionCirculation Research. 2006;99:E84-E84 September 1, 2006Vol 99, Issue 5 Advertisement Article InformationMetrics https://doi.org/10.1161/01.RES.0000241056.84659.59PMID: 16946140 Originally publishedSeptember 1, 2006 Keywordsvascular structure and functionmen and vascular diseasewomen and vascular diseasegender-related vascular diseaseestrogen receptor-alpha genotype (ESR1)estrogen receptor-alpha (ESR1)PDF download Advertisement" @default.
• W2164174927 created "2016-06-24" @default.
• W2164174927 creator A5014844497 @default.
• W2164174927 creator A5058934103 @default.
• W2164174927 creator A5065188755 @default.
• W2164174927 date "2006-09-01" @default.
• W2164174927 modified "2023-10-18" @default.
• W2164174927 title "Estrogen and Different Aspects of Vascular Disease in Women and Men" @default.
• W2164174927 cites W1539705587 @default.
• W2164174927 cites W1607047529 @default.
• W2164174927 cites W1989999505 @default.
• W2164174927 cites W1990077170 @default.
• W2164174927 cites W1991061750 @default.
• W2164174927 cites W1991998552 @default.
• W2164174927 cites W2038482691 @default.
• W2164174927 cites W2042111739 @default.
• W2164174927 cites W2048142894 @default.
• W2164174927 cites W2068132866 @default.
• W2164174927 cites W2071936488 @default.
• W2164174927 cites W2091916759 @default.
• W2164174927 cites W2094972031 @default.
• W2164174927 cites W2095807163 @default.
• W2164174927 cites W2097588925 @default.
• W2164174927 cites W2121398847 @default.
• W2164174927 cites W2127872440 @default.
• W2164174927 cites W2131324992 @default.
• W2164174927 cites W2132880294 @default.
• W2164174927 cites W2137432207 @default.
• W2164174927 cites W2147699037 @default.
• W2164174927 cites W2149060280 @default.
• W2164174927 cites W2155796155 @default.
• W2164174927 cites W2161527344 @default.
• W2164174927 cites W2164374136 @default.
• W2164174927 cites W2187824878 @default.
• W2164174927 cites W2316239431 @default.
• W2164174927 cites W2325814559 @default.
• W2164174927 cites W4253389549 @default.
• W2164174927 cites W4361868744 @default.
• W2164174927 doi "https://doi.org/10.1161/01.res.0000241056.84659.59" @default.
• W2164174927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16946140" @default.
• W2164174927 hasPublicationYear "2006" @default.
• W2164174927 type Work @default.
• W2164174927 sameAs 2164174927 @default.
• W2164174927 citedByCount "35" @default.
• W2164174927 countsByYear W21641749272012 @default.
• W2164174927 countsByYear W21641749272013 @default.
• W2164174927 countsByYear W21641749272014 @default.
• W2164174927 countsByYear W21641749272015 @default.
• W2164174927 countsByYear W21641749272016 @default.
• W2164174927 countsByYear W21641749272017 @default.
• W2164174927 countsByYear W21641749272020 @default.
• W2164174927 countsByYear W21641749272021 @default.
• W2164174927 countsByYear W21641749272022 @default.
• W2164174927 crossrefType "journal-article" @default.
• W2164174927 hasAuthorship W2164174927A5014844497 @default.
• W2164174927 hasAuthorship W2164174927A5058934103 @default.
• W2164174927 hasAuthorship W2164174927A5065188755 @default.
• W2164174927 hasBestOaLocation W21641749271 @default.
• W2164174927 hasConcept C126322002 @default.
• W2164174927 hasConcept C134018914 @default.
• W2164174927 hasConcept C2777164284 @default.
• W2164174927 hasConcept C2779134260 @default.
• W2164174927 hasConcept C42407357 @default.
• W2164174927 hasConcept C71924100 @default.
• W2164174927 hasConceptScore W2164174927C126322002 @default.
• W2164174927 hasConceptScore W2164174927C134018914 @default.
• W2164174927 hasConceptScore W2164174927C2777164284 @default.
• W2164174927 hasConceptScore W2164174927C2779134260 @default.
• W2164174927 hasConceptScore W2164174927C42407357 @default.
• W2164174927 hasConceptScore W2164174927C71924100 @default.
• W2164174927 hasIssue "5" @default.
• W2164174927 hasLocation W21641749271 @default.
• W2164174927 hasLocation W21641749272 @default.
• W2164174927 hasLocation W21641749273 @default.
• W2164174927 hasOpenAccess W2164174927 @default.
• W2164174927 hasPrimaryLocation W21641749271 @default.
• W2164174927 hasRelatedWork W1963710704 @default.
• W2164174927 hasRelatedWork W1995050400 @default.
• W2164174927 hasRelatedWork W1995647897 @default.
• W2164174927 hasRelatedWork W2013481652 @default.
• W2164174927 hasRelatedWork W2027180407 @default.
• W2164174927 hasRelatedWork W2101821182 @default.
• W2164174927 hasRelatedWork W2108578925 @default.
• W2164174927 hasRelatedWork W2109882125 @default.
• W2164174927 hasRelatedWork W2168803779 @default.
• W2164174927 hasRelatedWork W4232275671 @default.
• W2164174927 hasVolume "99" @default.
• W2164174927 isParatext "false" @default.
• W2164174927 isRetracted "false" @default.
• W2164174927 magId "2164174927" @default.
• W2164174927 workType "article" @default.